South Korea · Delayed Price · Currency is KRW Daelim Bath Statistics
Total Valuation
Daelim Bath has a market cap or net worth of KRW 73.48 billion. The enterprise value is 116.79 billion.
| Market Cap | 73.48B |
| Enterprise Value | 116.79B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Daelim Bath has 16.42 million shares outstanding. The number of shares has decreased by -1.32% in one year.
| Current Share Class | 16.42M |
| Shares Outstanding | 16.42M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 56.35% |
| Owned by Institutions (%) | n/a |
| Float | 5.50M |
Valuation Ratios
The trailing PE ratio is 4.95.
| PE Ratio | 4.95 |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | 2.69 |
| P/OCF Ratio | 2.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.13, with an EV/FCF ratio of 4.28.
| EV / Earnings | 7.87 |
| EV / Sales | 0.39 |
| EV / EBITDA | 4.13 |
| EV / EBIT | 5.91 |
| EV / FCF | 4.28 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.07 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | 2.74 |
| Interest Coverage | 7.55 |
Financial Efficiency
Return on equity (ROE) is 8.53% and return on invested capital (ROIC) is 6.58%.
| Return on Equity (ROE) | 8.53% |
| Return on Assets (ROA) | 3.60% |
| Return on Invested Capital (ROIC) | 6.58% |
| Return on Capital Employed (ROCE) | 8.82% |
| Weighted Average Cost of Capital (WACC) | 4.41% |
| Revenue Per Employee | 431.67M |
| Profits Per Employee | 21.19M |
| Employee Count | 700 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 4.40 |
Taxes
In the past 12 months, Daelim Bath has paid 5.41 billion in taxes.
| Income Tax | 5.41B |
| Effective Tax Rate | 27.02% |
Stock Price Statistics
The stock price has increased by +5.29% in the last 52 weeks. The beta is 0.37, so Daelim Bath's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +5.29% |
| 50-Day Moving Average | 5,478.80 |
| 200-Day Moving Average | 4,957.18 |
| Relative Strength Index (RSI) | 30.12 |
| Average Volume (20 Days) | 52,418 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daelim Bath had revenue of KRW 302.17 billion and earned 14.84 billion in profits. Earnings per share was 903.60.
| Revenue | 302.17B |
| Gross Profit | 84.53B |
| Operating Income | 19.95B |
| Pretax Income | 20.01B |
| Net Income | 14.84B |
| EBITDA | 28.50B |
| EBIT | 19.95B |
| Earnings Per Share (EPS) | 903.60 |
Balance Sheet
The company has 40.50 billion in cash and 74.77 billion in debt, with a net cash position of -34.27 billion or -2,087.17 per share.
| Cash & Cash Equivalents | 40.50B |
| Total Debt | 74.77B |
| Net Cash | -34.27B |
| Net Cash Per Share | -2,087.17 |
| Equity (Book Value) | 181.31B |
| Book Value Per Share | 10,496.42 |
| Working Capital | 8.72B |
Cash Flow
In the last 12 months, operating cash flow was 29.14 billion and capital expenditures -1.84 billion, giving a free cash flow of 27.30 billion.
| Operating Cash Flow | 29.14B |
| Capital Expenditures | -1.84B |
| Depreciation & Amortization | 8.55B |
| Net Borrowing | -9.15B |
| Free Cash Flow | 27.30B |
| FCF Per Share | 1,662.61 |
Margins
Gross margin is 27.97%, with operating and profit margins of 6.60% and 4.91%.
| Gross Margin | 27.97% |
| Operating Margin | 6.60% |
| Pretax Margin | 6.62% |
| Profit Margin | 4.91% |
| EBITDA Margin | 9.43% |
| EBIT Margin | 6.60% |
| FCF Margin | 9.04% |
Dividends & Yields
This stock pays an annual dividend of 180.00, which amounts to a dividend yield of 4.02%.
| Dividend Per Share | 180.00 |
| Dividend Yield | 4.02% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 16.86% |
| Buyback Yield | 1.32% |
| Shareholder Yield | 5.40% |
| Earnings Yield | 20.19% |
| FCF Yield | 37.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Daelim Bath has an Altman Z-Score of 1.9 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 6 |